D-0633-2024 Class III
FDA drug recall D-0633-2024 was initiated by Taro Pharmaceuticals U.S.A., Inc. on Aug 7, 2024 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: Out-of-specification results obtained for related impurities and slightly lower than the established level of the Hydrocortisone Assay obtained during… Affected quantity: 96 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 21, 2024
- Initiation Date
- Aug 7, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 96 vials
Product description
Hydrocortisone 1% & Acetic Acid 2% Otic Solution, 10 mL bottle, Rx only, Mfg by: Taro Pharmaceuticals, Inc., Brampton, Ontario, Canada L6T 1C1, Distributed by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-3007-01
Reason for recall
Failed Impurities/Degradation Specifications: Out-of-specification results obtained for related impurities and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.
Distribution pattern
Product was distributed to one distributor
Code information
Lot # AD12890, Exp 09/30/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0633-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026